Evidence map›Paper›PMID 17353535›Full record

ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2007

Management of acute decompensated heart failure.

Larry A Allen, Christopher M O'Connor

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. An integrated overview of acute heart failure: a narrative review of pathophysiological mechanisms and contributing factors.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failure.P & T : a peer-reviewed journal for formulary management · 2013
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. End points for clinical trials in acute heart failure syndromes.Journal of the American College of Cardiology · 2009
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 5 countries.

Larry A AllenDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Christopher M O'Connor
Duke Medical Center · USOtsuka Pharmaceutical (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute decompensated heart failure represents a heterogeneous group of disorders that typically present as dyspnea, edema and fatigue. Despite the high prevalence of this condition and its associated major morbidity and mortality, diagnosis can be difficult, and optimal treatment remains poorly defined. Identification of the acute triggers for the decompensation as well as noninvasive characterization of cardiac filling pressures and output is central to management. Diuretics, vasodilators, continuous positive airway pressure and inotropes can be used to alleviate symptoms. However, few agents currently available for the treatment of acute decompensated heart failure have been definitively shown in large prospective randomized clinical trials to provide meaningful improvements in intermediate-term clinical outcomes. Multiple novel therapies are being developed, but previous treatment failures indicate that progress in the management of acute decompensated heart failure is likely to be slow.

Indexed as

Defibrillators, ImplantableAcute DiseaseAgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsCardiotonic AgentsCombined Modality TherapyDiureticsFemaleFollow-Up StudiesHeart FailureHeart Function TestsHumansMaleMiddle AgedMineralocorticoid Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsCardiotonic AgentsDiureticsMineralocorticoid Receptor AntagonistsVasodilator Agents

Identifiers

PMID17353535
PMCPMC1808524
OpenAlexW2087948512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.